APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rifaximin Tablets Market Outlook and Growth Opportunities 2026

27 December 2025202 pages

Choose your research edition.

Industry ResearchRifaximin Tablets Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin Tablets Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Rifaximin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin Tablets Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Rifaximin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rifaximin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rifaximin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifaximin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rifaximin Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rifaximin Tablets market include Aden Healthcare, Alfasigma SpA, AS Lifesciences, Estrellas Life Sciences Private Limited, Gnova Biotech, Healthy Life Pharma Pvt. Ltd., Netprime Pharma, Norgine Limited and Nanchang Feihong Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rifaximin Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rifaximin Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rifaximin Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rifaximin Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Rifaximin Tablets Segment by Company

Aden Healthcare

Alfasigma SpA

AS Lifesciences

Estrellas Life Sciences Private Limited

Gnova Biotech

Healthy Life Pharma Pvt. Ltd.

Netprime Pharma

Norgine Limited

Nanchang Feihong Pharmaceutical Co., Ltd.

Shandong Zibo Xinda Pharmaceutical Co., Ltd.

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Sichuan Baili Pharmaceutical Co., Ltd.

Sichuan Mingxing Pharmaceutical Co., Ltd.

Tianjin Junan Biopharmaceutical Co., Ltd.

Chongqing Laimi Pharmaceutical Co., Ltd.

Chongqing Sino Biopharmaceutical Co., Ltd.

Rifaximin Tablets Segment by Type

0.1g

0.2g

Rifaximin Tablets Segment by Application

Clinic

Hospital

Other

Rifaximin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rifaximin Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rifaximin Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rifaximin Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Rifaximin Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rifaximin Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rifaximin Tablets industry.

Chapter 3: Detailed analysis of Rifaximin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rifaximin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rifaximin Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rifaximin Tablets Industry Trends Table 2. Rifaximin Tablets Industry Drivers Table 3. Rifaximin Tablets Industry Opportunities and Challenges Table 4. Rifaximin Tablets Industry Restraints Table 5. Global Rifaximin Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rifaximin Tablets Revenue Share by Company (2021-2026) Table 7. Global Rifaximin Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Rifaximin Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Rifaximin Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Rifaximin Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rifaximin Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Rifaximin Tablets Company, Product Type & Application Table 13. Global Rifaximin Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rifaximin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.1g Table 18. Significant Companies of 0.2g Table 19. Global Rifaximin Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Rifaximin Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Rifaximin Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Rifaximin Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Rifaximin Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Rifaximin Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rifaximin Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Rifaximin Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Rifaximin Tablets Sales Value Share by Type (2021-2026) Table 28. Global Rifaximin Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Other Table 32. Global Rifaximin Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Rifaximin Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Rifaximin Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Rifaximin Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Rifaximin Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Rifaximin Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Rifaximin Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Rifaximin Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Rifaximin Tablets Sales Value Share by Application (2021-2026) Table 41. Global Rifaximin Tablets Sales Value Share by Application (2027-2032) Table 42. Global Rifaximin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Rifaximin Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Rifaximin Tablets Sales Market Share by Region (2021-2026) Table 45. Global Rifaximin Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Rifaximin Tablets Sales Market Share by Region (2027-2032) Table 47. Global Rifaximin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Rifaximin Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Rifaximin Tablets Sales Value Share by Region (2021-2026) Table 50. Global Rifaximin Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Rifaximin Tablets Sales Value Share by Region (2027-2032) Table 52. Global Rifaximin Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Rifaximin Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Rifaximin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Rifaximin Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Rifaximin Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Rifaximin Tablets Sales Market Share by Country (2021-2026) Table 58. Global Rifaximin Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Rifaximin Tablets Sales Market Share by Country (2027-2032) Table 60. Global Rifaximin Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Rifaximin Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Rifaximin Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Rifaximin Tablets Sales Value Market Share by Country (2027-2032) Table 64. Aden Healthcare Company Information Table 65. Aden Healthcare Business Overview Table 66. Aden Healthcare Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Aden Healthcare Rifaximin Tablets Product Portfolio Table 68. Aden Healthcare Recent Development Table 69. Alfasigma SpA Company Information Table 70. Alfasigma SpA Business Overview Table 71. Alfasigma SpA Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Alfasigma SpA Rifaximin Tablets Product Portfolio Table 73. Alfasigma SpA Recent Development Table 74. AS Lifesciences Company Information Table 75. AS Lifesciences Business Overview Table 76. AS Lifesciences Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. AS Lifesciences Rifaximin Tablets Product Portfolio Table 78. AS Lifesciences Recent Development Table 79. Estrellas Life Sciences Private Limited Company Information Table 80. Estrellas Life Sciences Private Limited Business Overview Table 81. Estrellas Life Sciences Private Limited Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Estrellas Life Sciences Private Limited Rifaximin Tablets Product Portfolio Table 83. Estrellas Life Sciences Private Limited Recent Development Table 84. Gnova Biotech Company Information Table 85. Gnova Biotech Business Overview Table 86. Gnova Biotech Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Gnova Biotech Rifaximin Tablets Product Portfolio Table 88. Gnova Biotech Recent Development Table 89. Healthy Life Pharma Pvt. Ltd. Company Information Table 90. Healthy Life Pharma Pvt. Ltd. Business Overview Table 91. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Product Portfolio Table 93. Healthy Life Pharma Pvt. Ltd. Recent Development Table 94. Netprime Pharma Company Information Table 95. Netprime Pharma Business Overview Table 96. Netprime Pharma Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Netprime Pharma Rifaximin Tablets Product Portfolio Table 98. Netprime Pharma Recent Development Table 99. Norgine Limited Company Information Table 100. Norgine Limited Business Overview Table 101. Norgine Limited Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Norgine Limited Rifaximin Tablets Product Portfolio Table 103. Norgine Limited Recent Development Table 104. Nanchang Feihong Pharmaceutical Co., Ltd. Company Information Table 105. Nanchang Feihong Pharmaceutical Co., Ltd. Business Overview Table 106. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 108. Nanchang Feihong Pharmaceutical Co., Ltd. Recent Development Table 109. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Company Information Table 110. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Business Overview Table 111. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 113. Shandong Zibo Xinda Pharmaceutical Co., Ltd. Recent Development Table 114. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information Table 115. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview Table 116. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 118. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Development Table 119. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 120. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 121. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 123. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Development Table 124. Sichuan Baili Pharmaceutical Co., Ltd. Company Information Table 125. Sichuan Baili Pharmaceutical Co., Ltd. Business Overview Table 126. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 128. Sichuan Baili Pharmaceutical Co., Ltd. Recent Development Table 129. Sichuan Mingxing Pharmaceutical Co., Ltd. Company Information Table 130. Sichuan Mingxing Pharmaceutical Co., Ltd. Business Overview Table 131. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 133. Sichuan Mingxing Pharmaceutical Co., Ltd. Recent Development Table 134. Tianjin Junan Biopharmaceutical Co., Ltd. Company Information Table 135. Tianjin Junan Biopharmaceutical Co., Ltd. Business Overview Table 136. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 138. Tianjin Junan Biopharmaceutical Co., Ltd. Recent Development Table 139. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 140. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 141. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 143. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 144. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information Table 145. Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview Table 146. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio Table 148. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Rifaximin Tablets Distributors List Table 152. Rifaximin Tablets Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Rifaximin Tablets Product Image Figure 2. Global Rifaximin Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rifaximin Tablets Sales (2021-2032) & (K Units) Figure 5. Global Rifaximin Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Rifaximin Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.1g Image Figure 10. 0.2g Image Figure 11. Global Rifaximin Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Rifaximin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Rifaximin Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Rifaximin Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Rifaximin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Rifaximin Tablets Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Other Image Figure 20. Global Rifaximin Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Rifaximin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Rifaximin Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Rifaximin Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Rifaximin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Rifaximin Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Rifaximin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Rifaximin Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Rifaximin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Rifaximin Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Rifaximin Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Rifaximin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Rifaximin Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Rifaximin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Rifaximin Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Rifaximin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Rifaximin Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Rifaximin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Rifaximin Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Rifaximin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Rifaximin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Rifaximin Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Rifaximin Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Aden Healthcare
  • Alfasigma SpA
  • AS Lifesciences
  • Estrellas Life Sciences Private Limited
  • Gnova Biotech
  • Healthy Life Pharma Pvt. Ltd.
  • Netprime Pharma
  • Norgine Limited
  • Nanchang Feihong Pharmaceutical Co., Ltd.
  • Shandong Zibo Xinda Pharmaceutical Co., Ltd.
  • Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Sichuan Baili Pharmaceutical Co., Ltd.
  • Sichuan Mingxing Pharmaceutical Co., Ltd.
  • Tianjin Junan Biopharmaceutical Co., Ltd.
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Chongqing Sino Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rifaximin Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Rifaximin Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Rifaximin Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rifaximin Tablets Market Dynamics
  1. 2.1 Rifaximin Tablets Industry Trends
  2. 2.2 Rifaximin Tablets Industry Drivers
  3. 2.3 Rifaximin Tablets Industry Opportunities and Challenges
  4. 2.4 Rifaximin Tablets Industry Restraints
3 Rifaximin Tablets Market by Company
  1. 3.1 Global Rifaximin Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Rifaximin Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Rifaximin Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Rifaximin Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Rifaximin Tablets Company Ranking (2024-2026)
  6. 3.6 Global Rifaximin Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Rifaximin Tablets Company Product Type and Application
  8. 3.8 Global Rifaximin Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rifaximin Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rifaximin Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rifaximin Tablets Market by Type
  1. 4.1 Rifaximin Tablets Type Introduction
  2. 4.1.1 0.1g
  3. 4.1.2 0.2g
  4. 4.2 Global Rifaximin Tablets Sales Volume by Type
  5. 4.2.1 Global Rifaximin Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rifaximin Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Rifaximin Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Rifaximin Tablets Sales Value by Type
  9. 4.3.1 Global Rifaximin Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rifaximin Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Rifaximin Tablets Sales Value Share by Type (2021-2032)
5 Rifaximin Tablets Market by Application
  1. 5.1 Rifaximin Tablets Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Rifaximin Tablets Sales Volume by Application
  6. 5.2.1 Global Rifaximin Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rifaximin Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rifaximin Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rifaximin Tablets Sales Value by Application
  10. 5.3.1 Global Rifaximin Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rifaximin Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rifaximin Tablets Sales Value Share by Application (2021-2032)
6 Rifaximin Tablets Regional Sales and Value Analysis
  1. 6.1 Global Rifaximin Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rifaximin Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Rifaximin Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Rifaximin Tablets Sales by Region (2027-2032)
  5. 6.3 Global Rifaximin Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rifaximin Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rifaximin Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rifaximin Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Rifaximin Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rifaximin Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Rifaximin Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rifaximin Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Rifaximin Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rifaximin Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rifaximin Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rifaximin Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Rifaximin Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rifaximin Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rifaximin Tablets Sales Value Share by Country, 2025 VS 2032
7 Rifaximin Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Rifaximin Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rifaximin Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rifaximin Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Rifaximin Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Rifaximin Tablets Sales by Country (2027-2032)
  6. 7.4 Global Rifaximin Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rifaximin Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rifaximin Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rifaximin Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rifaximin Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rifaximin Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aden Healthcare
  2. 8.1.1 Aden Healthcare Company Information
  3. 8.1.2 Aden Healthcare Business Overview
  4. 8.1.3 Aden Healthcare Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aden Healthcare Rifaximin Tablets Product Portfolio
  6. 8.1.5 Aden Healthcare Recent Developments
  7. 8.2 Alfasigma SpA
  8. 8.2.1 Alfasigma SpA Company Information
  9. 8.2.2 Alfasigma SpA Business Overview
  10. 8.2.3 Alfasigma SpA Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Alfasigma SpA Rifaximin Tablets Product Portfolio
  12. 8.2.5 Alfasigma SpA Recent Developments
  13. 8.3 AS Lifesciences
  14. 8.3.1 AS Lifesciences Company Information
  15. 8.3.2 AS Lifesciences Business Overview
  16. 8.3.3 AS Lifesciences Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AS Lifesciences Rifaximin Tablets Product Portfolio
  18. 8.3.5 AS Lifesciences Recent Developments
  19. 8.4 Estrellas Life Sciences Private Limited
  20. 8.4.1 Estrellas Life Sciences Private Limited Company Information
  21. 8.4.2 Estrellas Life Sciences Private Limited Business Overview
  22. 8.4.3 Estrellas Life Sciences Private Limited Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Estrellas Life Sciences Private Limited Rifaximin Tablets Product Portfolio
  24. 8.4.5 Estrellas Life Sciences Private Limited Recent Developments
  25. 8.5 Gnova Biotech
  26. 8.5.1 Gnova Biotech Company Information
  27. 8.5.2 Gnova Biotech Business Overview
  28. 8.5.3 Gnova Biotech Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gnova Biotech Rifaximin Tablets Product Portfolio
  30. 8.5.5 Gnova Biotech Recent Developments
  31. 8.6 Healthy Life Pharma Pvt. Ltd.
  32. 8.6.1 Healthy Life Pharma Pvt. Ltd. Company Information
  33. 8.6.2 Healthy Life Pharma Pvt. Ltd. Business Overview
  34. 8.6.3 Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Healthy Life Pharma Pvt. Ltd. Rifaximin Tablets Product Portfolio
  36. 8.6.5 Healthy Life Pharma Pvt. Ltd. Recent Developments
  37. 8.7 Netprime Pharma
  38. 8.7.1 Netprime Pharma Company Information
  39. 8.7.2 Netprime Pharma Business Overview
  40. 8.7.3 Netprime Pharma Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Netprime Pharma Rifaximin Tablets Product Portfolio
  42. 8.7.5 Netprime Pharma Recent Developments
  43. 8.8 Norgine Limited
  44. 8.8.1 Norgine Limited Company Information
  45. 8.8.2 Norgine Limited Business Overview
  46. 8.8.3 Norgine Limited Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Norgine Limited Rifaximin Tablets Product Portfolio
  48. 8.8.5 Norgine Limited Recent Developments
  49. 8.9 Nanchang Feihong Pharmaceutical Co., Ltd.
  50. 8.9.1 Nanchang Feihong Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Nanchang Feihong Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nanchang Feihong Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  54. 8.9.5 Nanchang Feihong Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shandong Zibo Xinda Pharmaceutical Co., Ltd.
  56. 8.10.1 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  60. 8.10.5 Shandong Zibo Xinda Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  62. 8.11.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  66. 8.11.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Shenyang Tonglian Pharmaceutical Co., Ltd.
  68. 8.12.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  72. 8.12.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Sichuan Baili Pharmaceutical Co., Ltd.
  74. 8.13.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Sichuan Baili Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sichuan Baili Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  78. 8.13.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Sichuan Mingxing Pharmaceutical Co., Ltd.
  80. 8.14.1 Sichuan Mingxing Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Sichuan Mingxing Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sichuan Mingxing Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  84. 8.14.5 Sichuan Mingxing Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Tianjin Junan Biopharmaceutical Co., Ltd.
  86. 8.15.1 Tianjin Junan Biopharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Tianjin Junan Biopharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Tianjin Junan Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  90. 8.15.5 Tianjin Junan Biopharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Chongqing Laimi Pharmaceutical Co., Ltd.
  92. 8.16.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Chongqing Laimi Pharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  96. 8.16.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Chongqing Sino Biopharmaceutical Co., Ltd.
  98. 8.17.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Chongqing Sino Biopharmaceutical Co., Ltd. Rifaximin Tablets Product Portfolio
  102. 8.17.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rifaximin Tablets Value Chain Analysis
  2. 9.1.1 Rifaximin Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rifaximin Tablets Sales Mode & Process
  6. 9.2 Rifaximin Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rifaximin Tablets Distributors
  9. 9.2.3 Rifaximin Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst